Trade Summary

2 days ago, Klein Lawrence Otto, serving as Chief Executive Officer at Oruka Therapeutics, Inc. (ORKA), sold 75,000 shares at $91.83 per share, for a total transaction value of $6,887,484.48. Following this transaction, Klein Lawrence Otto now holds 925,580 shares of ORKA.

This sale represents a 7.50% decrease in Klein Lawrence Otto's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, September 1, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, September 1, 2026 at 6:35 PM ET, meaning the disclosure happened on the same day as the trade.

Oruka Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.